NCT03856112 2019-03-26Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 1/2 Withdrawn